USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Warszawski Uniwersytet Medyczny

USPTO PatentsView assignee record - 11 granted patents across 13 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

RSS updates for this company

The verdict

According to USPTO PatentsView, Warszawski ranks #25,530 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 13 technology areas.

#25,530
of 49,997 US assignees by volume
41st percentile
by Innovation Score (32.3/100)
14.6
avg claims per patent
-50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R25530 · Foreign Corporation #25,530 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 11 grants
  • MID-PACK #25,530/49,997
  • PHOTO-FINISH Volm Companies
  • CPC-FOCUS A61P · 13 areas
  • INNOV-THIN 32.3/100
  • CLAIMS-RICH 14.6 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -50% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Volm Companies, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Warszawski’s 32.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Warszawski

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Warszawski's Innovation Score is 32.3/100 (41st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Warszawski?

Each dot is one of Warszawski’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Warszawski’s own 14.6 claims/patent is ABOVE the 13.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Warszawski vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 10.910.91111.1 51015202530 Granted patents (volume) Avg claims / patent Volm Companies, Inc. - 11, 25.64Volm CompaniesVoltServer, Inc. - 11, 13.09VoltserverW. Morrison Consulting Group Inc. - 11, 20W Morrison Consul…Warren Industries Ltd. - 11, 10.82Warren IndustriesWeidplas GMBH - 11, 15.73WeidplasWeihai Hualing Opto-electronics Co., Ltd. - 11, 11.55Weihai Hualing Op…Well Being Digital Limited - 11, 9.36Well Being DigitalWella International Operations Switzerland Sarl - 11, 14.18Wella Internation…Warszawski Uniwersytet Medyczny - 11, 14.55Warszawski Uniwer…
Warszawski vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Warszawski's grants concentrate

Warszawski Uniwersytet Medyczny is a focused PatentsView assignee: 13 CPC subclasses with 72.7% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (3 grants) versus a trough of 1 in 2019. By volume, Warszawski sits between Volm Companies, Inc. and Wella International Operations Switzerland Sarl.

Warszawski's three-year grant acceleration

Warszawski Uniwersytet Medyczny shows 1 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Warszawski's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Warszawski holds 11 patents at rank #25,513, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Warszawski

By rank, the assignees closest to #25,513 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Warszawski's primary technology class.

Warszawski's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 41st percentile higher than 41% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 2015201720192020202120242025 2
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Warszawski Uniwersytet Medyczny patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 3 27.3%
2017 2 18.2%
2019 1 9.1%
2020 1 9.1%
2021 1 9.1%
2024 1 9.1%
2025partial year 2 18.2%

Which technologies does Warszawski Uniwersytet Medyczny patent most?

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Warszawski Uniwersytet Medyczny's patent record in context - here's where to go next.

  • Warszawski Uniwersytet Medyczny's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 72.7% of its portfolio - see every assignee active in that class. Explore A61P
  • Ranked #25,530 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Warszawski Uniwersytet Medyczny against Volm Companies, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 32.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.